Olyth
Live Rankings
Top Stocks
Top Influencers
60 Degrees Pharmaceuticals, Inc ($SXTPW) Stock Price, Chart & Sentiment on X | Olyth
Live Rankings
/
Top Stocks
/
SXTPW
SXTPW
60 Degrees Pharmaceuticals, Inc
52W High Breakout
$0.04
+$0.00 (+10.99%)
Loading Chart...
Live Ranking
Top Influencers
Top Stocks (30D)
Key Statistics
Market Cap
—
Forward P/E
—
EPS (TTM)
—
52-Week Return
—
50-Day Moving Avg
—
200-Day Moving Avg
—
Volume Today
1.66K
Avg Volume
1.66K
Day Range
$0.04 – $0.04
52-Week Range
$0.04 – $0.04
Open Price
$0.05
Previous Close
$0.04
Company Profile
Recent News
Company Profile
No profile description available.
SEC Filings
EDGAR Filings
Exchange Listing
Nasdaq.com
Recent News
GlobeNewswire
8/14/2026
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
GlobeNewswire
7/30/2026
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
7/29/2026
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
GlobeNewswire
7/1/2026
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
GlobeNewswire
7/8/2026
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases
GlobeNewswire
6/11/2026
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
MT Newswires
7/8/2026
60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal
MT Newswires
7/1/2026
60 Degrees Pharmaceuticals Says Safety Board Recommends Continuing Babesiosis Trial